BB Biotech AG
Latest statistics and disclosures from BB Biotech AG's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CELG, GILD, ISIS, INCY, VRTX. These five stock positions account for 63.33% of BB Biotech AG's total stock portfolio.
- Added to shares of GILD (+$93.48M), ALXN (+$24.64M), MDVN (+$13.47M), ARIA (+$5.42M), INCY, Endocyte, HALO.
- Reduced shares in these stocks: CELG (-$46.36M), MDCO (-$19.74M), VRTX (-$19.71M), BMRN (-$19.70M), ISIS (-$5.91M), IMGN, DNDN.
- As of March 31, 2013, BB Biotech AG has $1.27B in assets under management (AUM). Assets under management grew from a total value of $1.03B to $1.27B.
- Independent of market fluctuations, BB Biotech AG was a net buyer by $30.66M worth of stocks in the most recent quarter.
BB Biotech AG portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 20.78 | -14.00% | 2270186 | 115.91 | 124.91 |
| GILD | Gilead Sciences | 15.15 | +95.00% | 3920000 | 48.94 | 56.30 |
| ISIS | ISIS Pharmaceuticals | 10.29 | -4.00% | 7694172 | 16.94 | 20.66 |
| INCY | Incyte Corporation | 9.83 | +3.00% | 5313870 | 23.41 | 23.04 |
| VRTX | Vertex Pharmaceuticals Incorporated | 7.27 | -17.00% | 1674445 | 54.97 | 79.49 |
| ALXN | Alexion Pharmaceuticals | 5.22 | +59.00% | 717400 | 92.14 | 102.90 |
| MDVN | Medivation | 4.62 | +29.00% | 1249706 | 46.76 | 47.53 |
| IMGN | ImmunoGen | 4.35 | -3.00% | 3427934 | 16.07 | 16.29 |
| ARIA | Ariad Pharmaceuticals | 4.12 | +11.00% | 2887075 | 18.08 | 16.67 |
| ONXX | Onyx Pharmaceuticals | 3.84 | 546500 | 88.86 | 95.65 | |
| MDCO | Medicines Company | 2.61 | -37.00% | 987654 | 33.41 | 35.76 |
| HALO | Halozyme Therapeutics | 2.57 | 5646519 | 5.76 | 7.96 | |
| Endocyte | 2.30 | +13.00% | 2339345 | 12.45 | 0.00 | |
| BMRN | BioMarin Pharmaceutical | 2.05 | -43.00% | 417310 | 62.26 | 64.01 |
| THRX | Theravance | 1.66 | 888244 | 23.62 | 39.59 | |
| OPTR | Optimer Pharmaceuticals | 1.36 | 1446700 | 11.90 | 14.97 | |
| ACHN | Achillion Pharmaceuticals | 1.16 | 1679340 | 8.75 | 7.77 | |
| DNDN | Dendreon Corporation | 0.47 | -17.00% | 1264800 | 4.74 | 4.01 |
| IDIX | Idenix Pharmaceuticals | 0.35 | 1250000 | 3.54 | 4.17 |
Past 13F-HR SEC Filings for BB Biotech AG
- BB Biotech AG 2012 Q4 - filed Feb. 13, 2013
- BB Biotech AG 2012 Q3 - filed Nov. 6, 2012
- BB Biotech AG 2012 Q2 - filed Aug. 7, 2012
- BB Biotech AG 2012 Q1 - filed May 3, 2012
- BB Biotech AG 2011 Q4 - filed Feb. 7, 2012
- BB Biotech AG 2011 Q3 - filed Nov. 7, 2011
- BB Biotech AG 2011 Q2 - filed Aug. 9, 2011
- BB Biotech AG 2011 Q1 - filed May 9, 2011
- BB Biotech AG 2010 Q4 - filed Feb. 10, 2011